FTC Releases Second Interim Staff Report on Prescription Drug Middlemen

News Healthcare & Pharma Reports

Date: 14th Jan, 2025 Source: Federal Trade Commission Country: USA Original Source

Brief

On January 10, 2025, the Federal Trade Commission issued an update regarding FTC Releases Second Interim Staff Report on Prescription Drug Middlemen. The report analyzes the influence of pharmacy benefit managers (PBMs) on specialty generic drugs and finds significant price markups by PBMs for cancer, HIV, and other critical drugs.

This content is restricted.

Highlights content goes here...

This content is restricted.

Federal Trade Commission

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

FTC Releases Second Interim Staff Report on Prescription Drug Middlemen

Brief

Federal Trade Commission

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

FTC Releases Second Interim Staff Report on Prescription Drug Middlemen

Brief

Federal Trade Commission

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.